Mervan Bekdas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mervan Bekdas has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Selma Erdoğan Düzcü
Department of Pathology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu, Türkiye
4 shared publications - Ayhan Çetinkaya
Department of Physiology, Bolu Abant İzzet Baysal University Faculty of Medicine, Bolu,Turkey
3 shared publications - Hüseyin Kocabey
Department of Pediatrics, Bolu Abant Izzet Baysal University, Faculty of Medicine
3 shared publications - Erkan Kilinc
Department of Physiology, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
2 shared publications - Gökçe Kaya Dinçel
Department of Pediatrics, Bolu Abant Izzet Baysal University, Faculty of Medicine
2 shared publications - Hüseyin Altunhan
Necmettin Erbakan University Faculty Of Medicine, Neonatology, Konya, Türkiye
2 shared publications
Latest Publications
- Open Access
- 1 October 2025
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 31 (6) , 389-402
Effects of Auraptene on Myocardial Injury Secondary to Acute Lung Injury: An Experimental Study
Objective: Acute lung injury (ALI) is caused by an imbalance between pro-inflammatory and anti-inflammatory cytokines as well as oxidants and antioxidants. These imbalances and the resulting hypoxemia can affect various cells, especially the myocardium. Auraptene is known for its antioxidant and anti-inflammatory effects. The aim of this study was to determine whether auraptene can be used to treat both ALI and myocardial injury secondary to ALI. Methods: The study was conducted with 24 ALI and 16 sham rats. Zero hour:Blood sampling, followed by the 150μl saline (sham) or LPS (ALI) intratracheally. 24. Hour:Blood and organs ampling, followed by euthanize of the animals. The collected material was used for serum TNF-α, troponin T (TnT), pro-brain natriuretic peptide (BNP) and histologic examinations. Results: TNF-α levels were significantly lower in the LPS+auraptene group than in the LPS group (p=0.007). Increased pulmonary lymphocyte, neutrophil, hemorrhage and, fibroblast and histiocyte scores in LPS-induced ALI were significantly reduced by the use of auraptene (p<0.001, p=0.003, p=0.006 and, p=0.001, respectively). The BNP and TnT values in the LPS auraptene group were significantly lower compared to the LPS group (p=0.046 and, p=0.045, respectively). Histologically, cardiac degeneration, disorganization, congestion and inflammation scores were significantly lower in the LPS+Auraptene group than in the LPS group (p=0.005, p=0.006, p=0.002 and, p=0.036, respectively). Conclusions: This study showed that ALI can lead to myocardial injury. Our results also suggest that auraptene, which suppresses inflammation, can be used to treat both ALI and myocardial injury secondary to ALI.
- 1 October 2025
- Published by Pera Yayıncılık Hizmetleri in European Journal of Therapeutics
- Vol. 31 (6) , 389-402
Open AccessEffects of Auraptene on Myocardial Injury Secondary to Acute Lung Injury: An Experimental Study
Objective: Acute lung injury (ALI) is caused by an imbalance between pro-inflammatory and anti-inflammatory cytokines as well as oxidants and antioxidants. These imbalances and the resulting hypoxemia can affect various cells, especially the myocardium. Auraptene is known for its antioxidant and anti-inflammatory effects. The aim of this study was to determine whether auraptene can be used to treat both ALI and myocardial injury secondary to ALI. Methods: The study was conducted with 24 ALI and 16 sham rats. Zero hour:Blood sampling, followed by the 150μl saline (sham) or LPS (ALI) intratracheally. 24. Hour:Blood and organs ampling, followed by euthanize of the animals. The collected material was used for serum TNF-α, troponin T (TnT), pro-brain natriuretic peptide (BNP) and histologic examinations. Results: TNF-α levels were significantly lower in the LPS+auraptene group than in the LPS group (p=0.007). Increased pulmonary lymphocyte, neutrophil, hemorrhage and, fibroblast and histiocyte scores in LPS-induced ALI were significantly reduced by the use of auraptene (p<0.001, p=0.003, p=0.006 and, p=0.001, respectively). The BNP and TnT values in the LPS auraptene group were significantly lower compared to the LPS group (p=0.046 and, p=0.045, respectively). Histologically, cardiac degeneration, disorganization, congestion and inflammation scores were significantly lower in the LPS+Auraptene group than in the LPS group (p=0.005, p=0.006, p=0.002 and, p=0.036, respectively). Conclusions: This study showed that ALI can lead to myocardial injury. Our results also suggest that auraptene, which suppresses inflammation, can be used to treat both ALI and myocardial injury secondary to ALI.
- 18 March 2024
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
Hastanemizde Nutrisyonel Anemi Nedeniyle Takip Edilen Çocukların Değerlendirilmesi
Amaç:Anemi tüm dünyada yaygın olarak karşılaşılan önemli bir halk sağlığı sorunudur. Aneminin pek çok farklı nedeni olmakla birlikte nutrisyonel nedenler daha sık görülmektedir. Bu çalışmada amacımız ilimizdeki 6 ay-18 yaş arası nutrisyonel anemilerin tiplerini ve bunları etkileyen özellikleri incelemektir. Yöntem:Bu çalışmaya 2019-2021 arasındaki 3 yıllık süreçte hastanemiz Çocuk Sağlığı ve Hastalıkları polikliniklerinde nutrisyonel anemi tanısı konulan olgular çalışmaya dahil edildi. Bulgular:Çalışmamızdaki hastaların 2030 tanesi(%48.1) erkek, 2187 tanesi(%51.9) kızdı. Bu olgularımızın 1268 tanesi(%30.1) 6-24 ayları arasında, 1375 tanesi de(%32.6) 144 aydan büyüktü. Olguların 3110’u(%73.7) mikrositer, 781’i(%18.5) megaloblastik ve 326’sı da(%7.7) mikst tip anemi grubundaydı. Erkeklerle karşılaştırıldığında kızlarda TDBK yüksek iken, transferrin satürasyonu düşük idi(sırasıyla 368.6±57.5vs. 361.7±56.9, p=0.028 ve %19.9±11.3vs. 20.1±11.4, p=0.02). Megaloblastik ve mikst tip anemi gruplarına ait serum 25(OH)D vitamini düzeyleri mikrositer anemi grubundakilere göre anlamlı oranda düşüktü(sırasıyla 14.2±9.3vs. 15.8±9.9, p
- 18 March 2024
- Published by Ahi Evran Medical Journal, Kirsehir Ahi Evran University in Ahi Evran Medical Journal
Hastanemizde Nutrisyonel Anemi Nedeniyle Takip Edilen Çocukların Değerlendirilmesi
Amaç:Anemi tüm dünyada yaygın olarak karşılaşılan önemli bir halk sağlığı sorunudur. Aneminin pek çok farklı nedeni olmakla birlikte nutrisyonel nedenler daha sık görülmektedir. Bu çalışmada amacımız ilimizdeki 6 ay-18 yaş arası nutrisyonel anemilerin tiplerini ve bunları etkileyen özellikleri incelemektir. Yöntem:Bu çalışmaya 2019-2021 arasındaki 3 yıllık süreçte hastanemiz Çocuk Sağlığı ve Hastalıkları polikliniklerinde nutrisyonel anemi tanısı konulan olgular çalışmaya dahil edildi. Bulgular:Çalışmamızdaki hastaların 2030 tanesi(%48.1) erkek, 2187 tanesi(%51.9) kızdı. Bu olgularımızın 1268 tanesi(%30.1) 6-24 ayları arasında, 1375 tanesi de(%32.6) 144 aydan büyüktü. Olguların 3110’u(%73.7) mikrositer, 781’i(%18.5) megaloblastik ve 326’sı da(%7.7) mikst tip anemi grubundaydı. Erkeklerle karşılaştırıldığında kızlarda TDBK yüksek iken, transferrin satürasyonu düşük idi(sırasıyla 368.6±57.5vs. 361.7±56.9, p=0.028 ve %19.9±11.3vs. 20.1±11.4, p=0.02). Megaloblastik ve mikst tip anemi gruplarına ait serum 25(OH)D vitamini düzeyleri mikrositer anemi grubundakilere göre anlamlı oranda düşüktü(sırasıyla 14.2±9.3vs. 15.8±9.9, p
- Open Access
- 6 January 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (4) , 1619-1627
Plasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia
Neurogenic inflammation is involved in the development and progression of respiratory inflammatory diseases. However, its role in community-acquired pneumonia (CAP) remains unclear. We therefore aimed to investigate plasma levels of neurogenic inflammation-related neuropeptides, calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), and procalcitonin (PCT) in pediatric patients with CAP and to assess their diagnostic value in viral and bacterial/mixed pneumonia. A total of 124 pediatric patients with CAP (1 month-18 years old) and 56 healthy children of similar ages were prospectively enrolled. The patients were classified as viral (n = 99) and bacterial/mixed (n = 25) pneumonia. Plasma levels of the peptides were quantified by ELISA. ROC analysis was performed to evaluate possible diagnostic value of the peptides. While plasma levels of CGRP, VIP and PCT were significantly higher in patients with CAP than in the control group, respectively, NPY levels were significantly lower. Moreover, plasma levels of all neuropeptides and PCT were significantly higher in bacterial pneumonia patients compared to viral pneumonia patients. ROC analysis revealed that CGRP, SP and NPY had a diagnostic value in distinguishing viral and bacterial/mixed pneumonia.Conclusions: Our findings suggest that these neuropeptides may be implicated in pediatric CAP. CGRP, SP and NPY together may be a promising candidate in distinguishing viral and bacterial/mixed pneumonia, however, for this, further studies are needed. What is Known:• Neurogenic inflammation contributes to the development and progression of respiratory inflammatory diseases such as chronic obstructive pulmonary disease and bronchial asthma. What is New:• Plasma levels of neurogenic inflammation related neuropeptides calcitonin gene-related peptide, substance P, vasoactive intestinal peptide and neuropeptide Y are changed in pediatric community-acquired pneumonia. Calcitonin gene-related peptide, substance P and neuropeptide Y are promising candidates in distinguishing viral and bacterial/mixed pneumonia.
- 6 January 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (4) , 1619-1627
Open AccessPlasma levels of neurogenic inflammation related neuropeptides in pediatric patients with community-acquired pneumonia and their potential diagnostic value in distinguishing viral and bacterial pneumonia
Neurogenic inflammation is involved in the development and progression of respiratory inflammatory diseases. However, its role in community-acquired pneumonia (CAP) remains unclear. We therefore aimed to investigate plasma levels of neurogenic inflammation-related neuropeptides, calcitonin gene-related peptide (CGRP), substance P (SP), vasoactive intestinal peptide (VIP) and neuropeptide Y (NPY), and procalcitonin (PCT) in pediatric patients with CAP and to assess their diagnostic value in viral and bacterial/mixed pneumonia. A total of 124 pediatric patients with CAP (1 month-18 years old) and 56 healthy children of similar ages were prospectively enrolled. The patients were classified as viral (n = 99) and bacterial/mixed (n = 25) pneumonia. Plasma levels of the peptides were quantified by ELISA. ROC analysis was performed to evaluate possible diagnostic value of the peptides. While plasma levels of CGRP, VIP and PCT were significantly higher in patients with CAP than in the control group, respectively, NPY levels were significantly lower. Moreover, plasma levels of all neuropeptides and PCT were significantly higher in bacterial pneumonia patients compared to viral pneumonia patients. ROC analysis revealed that CGRP, SP and NPY had a diagnostic value in distinguishing viral and bacterial/mixed pneumonia.Conclusions: Our findings suggest that these neuropeptides may be implicated in pediatric CAP. CGRP, SP and NPY together may be a promising candidate in distinguishing viral and bacterial/mixed pneumonia, however, for this, further studies are needed. What is Known:• Neurogenic inflammation contributes to the development and progression of respiratory inflammatory diseases such as chronic obstructive pulmonary disease and bronchial asthma. What is New:• Plasma levels of neurogenic inflammation related neuropeptides calcitonin gene-related peptide, substance P, vasoactive intestinal peptide and neuropeptide Y are changed in pediatric community-acquired pneumonia. Calcitonin gene-related peptide, substance P and neuropeptide Y are promising candidates in distinguishing viral and bacterial/mixed pneumonia.
- 12 December 2023
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 135 (2) , 148-157
Protective and therapeutic effects of okra seed in acute nontraumatic brain injury
The purpose of this study was to examine the protective and therapeutic effects of okra (Abelmoschus esculentus [AE]) seed extract, with its known antioxidant, immunomodulatory, and anti-inflammatory properties, in an acetaminophen (paracetamol, N-acetyl- para-aminophenol)-induced model of hepatotoxicity and subsequent acute non-traumatic brain damage. Forty male Wistar rats were randomly divided into five equal groups, control, paracetamol (P), okra seed extract (AE), okra seed extract + paracetamol (P + AE), and okra seed extract + paracetamol + N-acetyl cysteine (NAC) (P + AE + N). AE was administered by oral gavage through a gastric tube at 600 mg/kg/day for seven days. On the eighth day of the procedure, a single 1 g/kg dose of paracetamol and 300 mg/kg NAC were injected via the intraperitoneal route 1.5 h after AE administration. Rat tissue specimens were subsequently subjected to biochemical and histopathological analyses. Levels of markers such as S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), and matrix membrane metalloproteinase-9 (MMP-9) were investigated from rat serum specimens. Malondialdehyde (MDA) and superoxide dismutase (SOD) were also measured to determine oxidant-antioxidant status. S100B, NSE, MMP-9, MDA levels, and SOD enzyme activities were examined using biochemical methods. MDA levels were significantly lower in the P + AE group and MMP-9 levels in the AE, P + AE, and P + AE + N groups compared to the P group. Histopathological examination results supported the biochemical findings. Okra seed extract exhibits a protective and therapeutic effect against non-traumatic brain damage resulting from acute paracetamol intoxication. We think that this benefit of AE derives from its antioxidant property.
- 12 December 2023
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 135 (2) , 148-157
Protective and therapeutic effects of okra seed in acute nontraumatic brain injury
The purpose of this study was to examine the protective and therapeutic effects of okra (Abelmoschus esculentus [AE]) seed extract, with its known antioxidant, immunomodulatory, and anti-inflammatory properties, in an acetaminophen (paracetamol, N-acetyl- para-aminophenol)-induced model of hepatotoxicity and subsequent acute non-traumatic brain damage. Forty male Wistar rats were randomly divided into five equal groups, control, paracetamol (P), okra seed extract (AE), okra seed extract + paracetamol (P + AE), and okra seed extract + paracetamol + N-acetyl cysteine (NAC) (P + AE + N). AE was administered by oral gavage through a gastric tube at 600 mg/kg/day for seven days. On the eighth day of the procedure, a single 1 g/kg dose of paracetamol and 300 mg/kg NAC were injected via the intraperitoneal route 1.5 h after AE administration. Rat tissue specimens were subsequently subjected to biochemical and histopathological analyses. Levels of markers such as S100 calcium-binding protein B (S100B), neuron-specific enolase (NSE), and matrix membrane metalloproteinase-9 (MMP-9) were investigated from rat serum specimens. Malondialdehyde (MDA) and superoxide dismutase (SOD) were also measured to determine oxidant-antioxidant status. S100B, NSE, MMP-9, MDA levels, and SOD enzyme activities were examined using biochemical methods. MDA levels were significantly lower in the P + AE group and MMP-9 levels in the AE, P + AE, and P + AE + N groups compared to the P group. Histopathological examination results supported the biochemical findings. Okra seed extract exhibits a protective and therapeutic effect against non-traumatic brain damage resulting from acute paracetamol intoxication. We think that this benefit of AE derives from its antioxidant property.
- Open Access
- 1 November 2023
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Indian Journal of Experimental Biology
- Vol. 61 (11) , 852-860
Abelmoschus esculentus (L.) Moench seed extract alleviates acute acetaminophen induced liver damage in rats
Acetaminophen (APAP) is one of the most regularly utilized medicines in children. When administered at the recommended doses, it is a safe medication. However, oxidative stress and inflammation caused by exposure to toxic doses lead to centrilobular hepatic necrosis. N-acetylcysteine (NAC) is utilized in the therapy, however it has potentially adverse effects. On the other hand, it is known that the seed of Abelmoschus esculentus (AE), a herbal product, possesses antioxidant and anti-inflammatory qualities. The aim of this study is to investigate whether AE may be used as an alternative to standart NAC therapy without fear of adverse effects in the treatment of acute APAP-induced liver injury. Forty male Wistar rats were placed into five groups: Control, AE, APAP, APAP+AE, and APAP+AE+NAC groups. Antioxidants such as native thiol and total thiol can be raised in the APAP group by taking just AE (p=0.043 and p=0.028, respectively). Anti-inflammatory indicators such as IL-10 can be increased in this group, while markers such as ALT, which is a sign of hepatotoxicity, can be decreased (p=0.005 and p<0.001, respectively). Histologically, AE has been shown to improve worsened congestion (p=0.003), cytoplasmic vacuolization (p=0.01), sinusoidal dilatation (p=0.001), Kupffer cell proliferation (p<0.001), and inflammation (p<0.001). These results suggest that AE seed may be a potential therapeutic agent for APAP-induced hepatotoxicity. The antioxidant and anti-inflammatory properties of AE seed contribute to this advantage.
- 1 November 2023
- Published by CSIR-National Institute of Science Communication and Policy Research (NIScPR) in Indian Journal of Experimental Biology
- Vol. 61 (11) , 852-860
Open AccessAbelmoschus esculentus (L.) Moench seed extract alleviates acute acetaminophen induced liver damage in rats
Acetaminophen (APAP) is one of the most regularly utilized medicines in children. When administered at the recommended doses, it is a safe medication. However, oxidative stress and inflammation caused by exposure to toxic doses lead to centrilobular hepatic necrosis. N-acetylcysteine (NAC) is utilized in the therapy, however it has potentially adverse effects. On the other hand, it is known that the seed of Abelmoschus esculentus (AE), a herbal product, possesses antioxidant and anti-inflammatory qualities. The aim of this study is to investigate whether AE may be used as an alternative to standart NAC therapy without fear of adverse effects in the treatment of acute APAP-induced liver injury. Forty male Wistar rats were placed into five groups: Control, AE, APAP, APAP+AE, and APAP+AE+NAC groups. Antioxidants such as native thiol and total thiol can be raised in the APAP group by taking just AE (p=0.043 and p=0.028, respectively). Anti-inflammatory indicators such as IL-10 can be increased in this group, while markers such as ALT, which is a sign of hepatotoxicity, can be decreased (p=0.005 and p<0.001, respectively). Histologically, AE has been shown to improve worsened congestion (p=0.003), cytoplasmic vacuolization (p=0.01), sinusoidal dilatation (p=0.001), Kupffer cell proliferation (p<0.001), and inflammation (p<0.001). These results suggest that AE seed may be a potential therapeutic agent for APAP-induced hepatotoxicity. The antioxidant and anti-inflammatory properties of AE seed contribute to this advantage.
- Open Access
- 15 February 2023
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 3 (1) , 9-15
The effects of intravenous paracetamol use on blood parameters in the treatment of patent ductus arteriosus
Aim: Patent ductus arteriosus (PDA), a cause of significant hemodynamic imbalance in newborn babies, can be treated using pharmacological or surgical methods. The purpose of this study was to compare intravenous (IV) paracetamol in newborns with hemodynamically significant PDA, with indomethacin and ibuprofen in terms of changes caused in blood parameters.Methods: Intravenous paracetamol was used for 3-6 days at 4x15 mg/kg/dose in cases diagnosed with PDA and admitted for follow-up between November 2014 and December 2015, and unable to receive oral medication or with contraindications for indomethacin-ibuprofen use. These cases were investigated retrospectively in terms of changes in pre and post-treatment AST (aspartate aminotransferase), ALT (alanine aminotransferase), urea, creatinine, platelet, and neutrophil values.Results: Intravenous paracetamol was administered to 10 cases of PDA, diagnosed between November 2014 and December 2015. Prior to paracetamol therapy, an increase in urea values was present in one case, increased AST in two, and decreased platelet values in two. Post-treatment values returned to normal ranges in all cases, and hemodynamic improvement was observed after the closure of the ductus arteriosus.Conclusion: Our analysis of its effect on PDA closure and its potential side-effect profile in patient blood parameters compared to other known therapeutic agents indicates that intravenous paracetamol, which is easily available and accessible in Turkey, may be an important option for the treatment of PDA.
- 15 February 2023
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 3 (1) , 9-15
Open AccessThe effects of intravenous paracetamol use on blood parameters in the treatment of patent ductus arteriosus
Aim: Patent ductus arteriosus (PDA), a cause of significant hemodynamic imbalance in newborn babies, can be treated using pharmacological or surgical methods. The purpose of this study was to compare intravenous (IV) paracetamol in newborns with hemodynamically significant PDA, with indomethacin and ibuprofen in terms of changes caused in blood parameters.Methods: Intravenous paracetamol was used for 3-6 days at 4x15 mg/kg/dose in cases diagnosed with PDA and admitted for follow-up between November 2014 and December 2015, and unable to receive oral medication or with contraindications for indomethacin-ibuprofen use. These cases were investigated retrospectively in terms of changes in pre and post-treatment AST (aspartate aminotransferase), ALT (alanine aminotransferase), urea, creatinine, platelet, and neutrophil values.Results: Intravenous paracetamol was administered to 10 cases of PDA, diagnosed between November 2014 and December 2015. Prior to paracetamol therapy, an increase in urea values was present in one case, increased AST in two, and decreased platelet values in two. Post-treatment values returned to normal ranges in all cases, and hemodynamic improvement was observed after the closure of the ductus arteriosus.Conclusion: Our analysis of its effect on PDA closure and its potential side-effect profile in patient blood parameters compared to other known therapeutic agents indicates that intravenous paracetamol, which is easily available and accessible in Turkey, may be an important option for the treatment of PDA.
- Open Access
- 15 June 2022
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 2 (2) , 112-122
The effect of Anatolian syrup on experimentally induced acetaminophen and lipopolysaccharide associated acute kidney injury
- 15 June 2022
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 2 (2) , 112-122
Open AccessThe effect of Anatolian syrup on experimentally induced acetaminophen and lipopolysaccharide associated acute kidney injury
- Open Access
- 15 December 2021
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 1 (3) , 100-102
Supraventricular Tachycardia Induced by Nasal Continuous Positive Airway Pressure
The use of noninvasive ventilation in the treatment of respiratory failure has increased in recent years. Nasal continuous positive airway pressure, a noninvasive method of ventilation, is thought to decrease the incidence of arrhythmias, but this case report presents supraventricular tachycardia attacks secondary to nasal continuous positive airway pressure. A 15-month-old boy was admitted to the intensive care unit with diagnoses of sepsis, disseminated intravascular coagulopathy, acute renal failure, and myocarditis. Supraventricular tachycardia attacks started after nasal continuous positive airway pressure but became regular after switching to invasive mechanical ventilation.
- 15 December 2021
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 1 (3) , 100-102
Open AccessSupraventricular Tachycardia Induced by Nasal Continuous Positive Airway Pressure
The use of noninvasive ventilation in the treatment of respiratory failure has increased in recent years. Nasal continuous positive airway pressure, a noninvasive method of ventilation, is thought to decrease the incidence of arrhythmias, but this case report presents supraventricular tachycardia attacks secondary to nasal continuous positive airway pressure. A 15-month-old boy was admitted to the intensive care unit with diagnoses of sepsis, disseminated intravascular coagulopathy, acute renal failure, and myocarditis. Supraventricular tachycardia attacks started after nasal continuous positive airway pressure but became regular after switching to invasive mechanical ventilation.